The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Fully anticipated.
Nothing goes up in a straight line, there has to be a re-trace at some point, traders take their profile share price pulls back, buyer come back in price rises, its how the stock market works.
@nicely......you do make me chuckle pal.
gla glth x
I will go for 20p
I'll go for a Friday closing price of 31p
Thank you Sadoldgit for posting that summary, and your view. Very appreciated of your time.
And I'll take a look through the board for historic info too.
Look forward to 8am.
Your such a delusional fool and I understand why people block you.
Good morning cupacoffee.
Suggest you look at RNS,s
Sareum experienced a problem with MHRA approval for SDC1801, now Sareum had tested in preclinical with 30 x treatment dose with no adverse effects.
MHRA requested more clarification, but exactly what this is we do not know.
Cut a long story short it has subsequently entered phase 1 clinical trial in the land of down under.
A further setback was Sierra Oncology returned the license for 737 back to the CPF at end of 22.
No reason given but l do have my views on this.
Subsequently SRA737 has now been on licensed to a US private pharma of which the details are not disclosed. I believe the signing of the contract is still yet to take place.
Most difficult set back was Riverfort Global finance equity release deal.
The price of Sar dropped from around 300p per share and with set backs by MHRA and delay, the return of 737 the SP suffered taking to around 105p.
Deal with Riverfort in August 23 caused a rapid decline of SP due to the finance described as a death spiral.
In effect rather than pay back loan in cash they take shares at a discounted price plus fees and options on top.
The more the share fall the more shares that have to he issued and the process continues until nothing is left.
Look at Riverfort finance and how companies have been devastated!
Sareum due to the terms contained within the contract could not draw down a further 300k
Share holders many of which are here raised under the WRAP offer 1.2 million pounds of which initially were capped at 300k pounds.
As a result Sareum now have sufficient funding to complete and evaluate phase 1a safety data in SDC1801.
A matter of a 2 to 3 hundred thousand pounds remains owing to Riverfort. We the rising shareprice shares will be issued to RF as they request. They have been off loading shares at a rapid rate.
The result the RF finance no longer has a stranglehold on the SP and the price has risen from a low of 10p.
To achieve the appropriate value Sareum had prior to Riverfort and the number of additional.shares issued you are looking at circa 70p per share which should be easily achievable.
News of the WRAP funding and non reliance on RF death spiral finance has removed the devastating downward pressure of Sareum.SP
Regards
This just strong buy and hold for substantial reward.Company will decide.
This used to trade 450p and now 27p.Way over done stock.Now everything is back to track.seller cleared.Trial results due.asset payment by big Pharma due..This looks win win situation for investment.DYOR.
Given you are on this board just read the threads....
Funny guy = filtered
Tomorrow going to be big day.
Have all turned up which again confirms why this is just a short term play.
People be careful
Sure can.
You can find recent news here;
https://www.bbc.co.uk/
Knew I'd find it somewhere - https://apps.dtic.mil/sti/pdfs/AD1087498.pdf
5. CHANGES/PROBLEMS:
We received a no cost extension for this project in April 2018. The PI on this project, Dr. Abhishek
Trigunaite, had to travel to his home country (India) for immigration related issues (VISA stamping).
Because of the unanticipated length of the processing time, he was required to stay in India for nearly
3 months and only able to return close to the termination date of the project. This loss of effort meant
that we were unable to perform the long-term dosing studies prior to the termination date of the grant.
Additionally, at the beginning of this award we had only proposed to look at only one strain of lupus
prone mice ((NZBxNZW) F1 mice) but later during the scientific review of the proposal, it was
decided to include a second mouse model (MRL/lpr) in the study. This increase in the animal number
for the short term (4-6 week) treatment did not leave us with enough funds to perform a long-term
survival study.
Apologies for the simplistic question. But why the jump in the last couple of days?
My late farther bought into SAR years ago, but passed away in 2019. The shares were sold off as part of the estate, but he told me to watch them, as they are on to something good. This was all before the consolidation and subsequent SP fall.
SAR is part of my LSE portfolio, but I'm not invested. Could someone point me in the direction of recent news please?
TIA
Hi Celtic - the trial was with 1802 and the lead researcher had to return to India due to their visa running out or family issues so the work was never completed.
https://www.pharmiweb.com/press-release/2020-07-24/encouraging-preclinical-results-generated-with-sareum-s-tyk2jak1-inhibitors-in-a-disease-model-of-lupus
I'll try and find the actual project doc on the US Military site.
Hi sadoldgit. Hope you are ok mate. Any views on our tyk2 in lupus. A study was done in the us army with it
Did we ever get data or one to leave for that indication. Thanks
There certainly are Carter19.
They take great delight reading here but unfortunately they cannot understand or refuse to understand anything that goes against their own spiteful, hate filled, agenda.
I don't mind rattling their cage now and again even if the lights are on but no one at home.
Steady rises should be achieved tomorrow and next week with a substantial rise on positive RNS.
Regards
Good evening MegRS300,
Yes a pound a share is easily achievable and we are climbing towards that as the realisation of the Riverfort Finance deal is losing its stranglehold.
Indeed, we are further forward in development of 1801 too
Riverfort will be gone soon, very soon!
A fund raise l believe will come soon, phase 2a trial which will lead into phase 2b.
At this stage the value of SDC will rise appreciably as you well know.
It is indeed a competitive market but pretty certain we will have nailed Psoriasis, precisiin biomarker data will give Indication as to suitability in other indication.
Long and good patent protection an added bonus.
Regards
Way over done and huge potential opportunity.Some pips sell for small profit then start deramping.
I tend to stay away from ADVN, a few Lunatics over there.
Paragraph relates to the gruesome twosome over on ADVN,
Apologies for any confusion caused here.
I am fully aware of this Damion and they are well aware that us investors are not happy with the debacle of RF and possibly Peel Hunt. This kind of thing goes on unfortunately, legalized corruption in many peoples eyes.